{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:56:42Z","timestamp":1790607402800,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH","award":["5T32HL007106-45"],"award-info":[{"award-number":["5T32HL007106-45"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08822-5","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T15:11:01Z","timestamp":1754147461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Validation of the age, neutrophil to lymphocyte ratio, C reactive protein score on 28\u00a0day mortality in the National COVID cohort collaborative"],"prefix":"10.1038","volume":"15","author":[{"given":"Benjamin J.","family":"Sines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal K.","family":"Jakharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Huan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Appleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Stephen","family":"DeCherney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Mock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Bradley","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"8822_CR1","unstructured":"United States of America: WHO Coronavirus Disease (COVID-19). Dashboard https:\/\/covid19.who.int\/region\/amro\/country\/us. Accessed 24 August 2022."},{"issue":"10","key":"8822_CR2","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.7326\/M21-1991","volume":"174","author":"S Garg","year":"2021","unstructured":"Garg, S. et al. Clinical trends among U.S. Adults hospitalized with COVID-19, March to December 2020: A cross-sectional study. Ann. Intern. Med. 174 (10), 1409\u20131419 (2021).","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"8822_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1080\/07853890.2020.1840621","volume":"53","author":"N Broman","year":"2021","unstructured":"Broman, N. et al. IL-6 and other biomarkers as predictors of severity in COVID-19. Ann. Med. 53 (1), 410\u2013412 (2021).","journal-title":"Ann. Med."},{"key":"8822_CR4","doi-asserted-by":"crossref","unstructured":"Mueller, A. A. et al. Inflammatory biomarker trends predict respiratory decline in COVID-19 patients. Cell Rep. Med. 1(17). (2020).","DOI":"10.1016\/j.xcrm.2020.100144"},{"key":"8822_CR5","doi-asserted-by":"crossref","unstructured":"Tan, Y. et al. Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19. Cell Discov. 7(42). (2021).","DOI":"10.1038\/s41421-021-00274-1"},{"issue":"3","key":"8822_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.12788\/jhm.3560","volume":"16","author":"Z Cui","year":"2021","unstructured":"Cui, Z. et al. Early and significant reductions in C-reactive protein levels after corticosteroid therapy is associated with reduced mortality in patients with COVID-19. J. Hosp. Med. 16 (3), 142\u2013148 (2021).","journal-title":"J. Hosp. Med."},{"key":"8822_CR7","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DMD Valle","year":"2020","unstructured":"Valle, D. M. D. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26, 1636\u20131643 (2020).","journal-title":"Nat. Med."},{"issue":"5","key":"8822_CR8","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.chest.2020.11.050","volume":"159","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. Corticosteroid therapy is associated with improved outcome in critically ill patients with COVID-19 with hyper inflammatory phenotype. Chest Infect. 159 (5), 1793\u20131802 (2021).","journal-title":"Chest Infections"},{"issue":"8","key":"8822_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"RECOVERY Collaborative Group","year":"2021","unstructured":"RECOVERY Collaborative Group et al. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 384 (8), 693\u2013704 (2021).","journal-title":"N Engl. J. Med."},{"key":"8822_CR10","doi-asserted-by":"crossref","unstructured":"Bradley, P. et al. Utility of established prognostic scores in COVID-19 hospital admissions: Multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA. BMJ Open. Resp. Res 7e000729. (2020).","DOI":"10.1136\/bmjresp-2020-000729"},{"key":"8822_CR11","doi-asserted-by":"publisher","first-page":"18638","DOI":"10.1038\/s41598-021-97332-1","volume":"11","author":"A Jones","year":"2021","unstructured":"Jones, A. et al. External validation of the 4\u00a0C mortality score among COVID-19 patients admitted to hospital in Ontario, Canada: A retrospective study. Sci. Rep. 11, 18638 (2021).","journal-title":"Sci. Rep."},{"issue":"1","key":"8822_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7326\/M20-3905","volume":"174","author":"BT Garibaldi","year":"2020","unstructured":"Garibaldi, B. T. et al. Patient trajectories among persons hospitalized for COVID-19: A cohort study. Ann. Intern. Med. 174 (1), 33\u201341 (2020).","journal-title":"Ann. Intern. Med."},{"key":"8822_CR13","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s00134-021-06524-w","volume":"47","author":"Y Lombardi","year":"2021","unstructured":"Lombardi, Y. et al. External validation of prognostic scores for COVID-19: A multicenter cohort study of patients hospitalized in greater Paris university hospitals. Intens. Care Med. 47, 1426\u20131439 (2021).","journal-title":"Intensive Care Med."},{"key":"8822_CR14","doi-asserted-by":"crossref","unstructured":"Lu, C. et al. The age-neutrophil to lymphocyte Ratio-C reactive protein (ARC) score: Predicting mortality in patients with COVID-19 infection receiving dexamethasone therapy. Presented at: ATS 2022; San Francisco, CA.","DOI":"10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A2923"},{"issue":"3","key":"8822_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/jamia\/ocaa196","volume":"28","author":"MA Haendel","year":"2021","unstructured":"Haendel, M. A. et al. The National COVID cohort collaborative (N3C): Rationale, design, infrastructure, and deployment. J. Am. Med. Inform. Assoc. 28 (3), 427\u2013443 (2021).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"8822_CR16","unstructured":"Centers for Disease Control and Prevention. COVID Data Tracker. Atlanta, GA: US Department of Health and Human Services, CDC; (2022). https:\/\/covid.cdc.gov\/covid-data-tracker. Accessed December 12."},{"key":"8822_CR17","doi-asserted-by":"crossref","unstructured":"Ingraham, N. E., Jones, E. K., King, S. & Dries, J., et al. Re-aiming equity evaluation in clinical decision support: A scoping review of equity assessments in surgical decision support systems. AnnSurg. 277, 359\u2013364. (2023).","DOI":"10.1097\/SLA.0000000000005661"},{"key":"8822_CR18","doi-asserted-by":"crossref","unstructured":"Lupei, M. I. et al., et al. A 12-hospital prospective evaluation of a clinical decision support prognostic algorithm based on logistic regression as a form of machine learning to facilitate decision making for patients with suspected COVID-19. PLoS ONE. 17(1). (2022).","DOI":"10.1371\/journal.pone.0262193"},{"key":"8822_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.imlet.2020.06.013","volume":"225","author":"S Tavakolpour","year":"2020","unstructured":"Tavakolpour, S., Rakhshandehroo, T., Wei, E. X. & Rashidian, M. Lymphopenia during the COVID-19 infection: What it shows and what can be learned. Immunol. Lett. 225, 31\u201332 (2020).","journal-title":"Immunol. Lett."},{"issue":"1","key":"8822_CR20","first-page":"54","volume":"24","author":"AS Fauci","year":"1976","unstructured":"Fauci, A. S. Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function. Clin. Exp. Immunol. 24 (1), 54\u201362 (1976).","journal-title":"Clin. Exp. Immunol."},{"key":"8822_CR21","unstructured":"Wolfe, C. R. et al. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): A randomised, double-blind, double placebo-controlled trial. Lancet Respir. Med. (2022)."},{"key":"8822_CR22","doi-asserted-by":"crossref","unstructured":"Appleton, L. et al. The Kinetics of Blood Soluble Mediators in Patients Requiring Hospitalization for COVID-19 Infection before and during Dexamethasone Therapy (ATS, 2022).","DOI":"10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A3549"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08822-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:23:30Z","timestamp":1757334210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08822-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8822"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08822-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the principles of the Declaration of Helsinki, institutional review board approval was obtained from the University of North Carolina Office of Human Research Ethics before the start of the study (IRB study number 22\u20130220, \u201cExternal cohort validation of the ARC score for COVID-19 28-day mortality and escalation in O2 therapy in hospitalized patients,\u201d date of approval: March 3, 2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28254"}}